Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Hamida M. Abou-Shleib"'
Autor:
Hamida M. Abou-Shleib, Yasmine Fathy Mohamed, Amal M Khalil, Nadia Mohamed El-Guink, Moustafa A. El-Nakeeb
Publikováno v:
Brazilian Journal of Microbiology, Volume: 47, Issue: 2, Pages: 381-388, Published: JUN 2016
Brazilian Journal of Microbiology, Vol 47, Iss 2, Pp 381-388 (2016)
Brazilian Journal of Microbiology v.47 n.2 2016
Brazilian Journal of Microbiology
Sociedade Brasileira de Microbiologia (SBM)
instacron:SBM
Brazilian Journal of Microbiology, Vol 47, Iss 2, Pp 381-388 (2016)
Brazilian Journal of Microbiology v.47 n.2 2016
Brazilian Journal of Microbiology
Sociedade Brasileira de Microbiologia (SBM)
instacron:SBM
Pan-drug resistant Gram-negative bacteria, being resistant to most available antibiotics, represent a huge threat to the medical community. Colistin is considered the last therapeutic option for patients in hospital settings. Thus, we were concerned
Autor:
Mohammed Bahey-El-Din, Nadia El Guink, Hamida M. Abou-Shleib, Amany Abdel-Bary, Mona Ahmed Elhosary
Publikováno v:
Microbial pathogenesis. 131
Pseudomonas aeruginosa is a notorious pathogen with increasing multi-drug resistance. This situation makes it urgent to develop a prophylactic vaccine against this pathogen. Different virulence factors play a crucial role in P. aeruginosa infection.
Publikováno v:
Letters in applied microbiology. 65(6)
Mycobacterium tuberculosis infection constitutes a global threat that results in significant morbidity and mortality worldwide. Efficient and early diagnosis of tuberculosis (TB) is of paramount importance for successful treatment. The aim of the cur
Autor:
Mohammed Bahey-El-Din, Radwa Ewaisha, Eglal I. Amer, Amal M Khalil, Shereen F. Mossallam, Hamida M. Abou-Shleib
Publikováno v:
Experimental Parasitology. 145:51-60
Schistosomiasis continues to be a serious helminthic disease that is widespread in many regions in the world. Disease management relies mainly on early treatment with praziquantel, nevertheless, re-infection rates can still be high. An effective vacc
Autor:
Shereen F. Mossallam, Hamida M. Abou-Shleib, Mohammed Bahey-El-Din, Amal M Khalil, Radwa Ewaisha
Publikováno v:
Journal of Helminthology. 89:764-768
Schistosoma mansonicauses intestinal schistosomiasis, a disease that is prevalent in several regions worldwide. To date, a protective vaccine againstS. mansoniis still lacking. Several promising antigens have been discovered and evaluated for vaccine
Publikováno v:
Egyptian Journal of Medical Microbiology. 22:123-130
Autor:
Moustafa A. El-Nakeeb, Omar M. El-Halfawy, Amal M Khalil, Hoda G. Omar, Hamida M. Abou-Shleib
Publikováno v:
APMIS. 120:215-220
Antibiotic resistance represents a serious problem that complicates microbial infection. The use of 'helper compounds' capable of enhancing the antimicrobial activity of antibiotics is being investigated. Azelastine, a new generation antihistaminic,
Autor:
Eglal I. Amer, Radwa Ewaisha, Mohammed Bahey-El-Din, Shereen F. Mossallam, Amal M Khalil, Hamida M. Abou-Shleib
Publikováno v:
BMC Infectious Diseases
Background Schistosoma mansoni infection represents a major cause of morbidity and mortality in many areas of the developing world. Effective vaccines against schistosomiasis are not available and disease management relies mainly on treatment with th
Publikováno v:
Journal of infection in developing countries. 9(10)
Introduction: Pseudomonas aeruginosa is one of the most virulent nosocomial pathogens worldwide. Quorum sensing (QS) regulates the production of pathogenic virulence factors and biofilm formation in P. aeruginosa. The four genes lasR, lasI, rhlR,and
Publikováno v:
The International Arabic Journal of Antimicrobial Agents.
Background: Recently there has been a growing concern that the indiscriminate use of antimicrobial agents in the household, food industry and in hospitals may contribute to the emergence of bacteria resistant to antibiotics. Aim of the work: To detec